| Literature DB >> 32946266 |
Naoya Miyashita1, Masafumi Horie2, Hiroshi I Suzuki3,4, Minako Saito1, Yu Mikami1,5, Kenichi Okuda1,5, Richard C Boucher5, Maho Suzukawa6, Akira Hebisawa6, Akira Saito1,7, Takahide Nagase1.
Abstract
Fibroblasts provide a structural framework for multiple organs and are essential for wound repair and fibrotic processes. Here, we demonstrate functional roles of FOXL1 (forkhead box L1), a transcription factor that characterizes the pulmonary origin of lung fibroblasts. We detected high FOXL1 transcripts associated with DNA hypomethylation and super-enhancer formation in lung fibroblasts, which is in contrast with fibroblasts derived from other organs. RNA in situ hybridization and immunohistochemistry in normal lung tissue indicated that FOXL1 mRNA and protein are expressed in submucosal interstitial cells together with airway epithelial cells. Transcriptome analysis revealed that FOXL1 could control a broad array of genes that potentiate fibroblast function, including TAZ (transcriptional coactivator with PDZ-binding motif)/YAP (Yes-associated protein) signature genes and PDGFRα (platelet-derived growth factor receptor-α). FOXL1 silencing in lung fibroblasts attenuated cell growth and collagen gel contraction capacity, underscoring the functional importance of FOXL1 in fibroproliferative reactions. Of clinical importance, increased FOXL1 mRNA expression was found in fibroblasts of idiopathic pulmonary fibrosis lung tissue. Our observations suggest that FOXL1 regulates multiple functional aspects of lung fibroblasts as a key transcription factor and is involved in idiopathic pulmonary fibrosis pathogenesis.Entities:
Keywords: FOXL1; cap analysis of gene expression; fibroblast; idiopathic pulmonary fibrosis; super-enhancer
Mesh:
Substances:
Year: 2020 PMID: 32946266 PMCID: PMC8017595 DOI: 10.1165/rcmb.2019-0396OC
Source DB: PubMed Journal: Am J Respir Cell Mol Biol ISSN: 1044-1549 Impact factor: 6.914